Emtricitabine, Rilpivirine, Tenofovir disoproxil

EVIPLERA 200 mg/25 mg/245 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

200 mg + 27,5 mg + 300 mg comprimido recubierto con películaSpainMarketedAuthorised 25 Jan 2012

In other countries

The same active substances on other registers, the same brand first.

EvipleraEuropean Union · Gilead Sciences International LtdSame brand
EvipleraCroatiaSame brand
Eviplera 200 mg/25 mg/245 mg, filmomhulde tablettenNetherlands · Filmomhulde tablet · Gilead Sciences Ireland UCSame brand
Eviplera®Serbia · 200mg+245mg+25mg · film tableta · Medicopharmacia DOO BeogradSame brand
CompleraCanada · 200 MG + 25 MG + 300 MG · Tablet · Gilead Sciences Canada INCSame form
Emtricitabine, Rilpivirine and Tenofovir Disoproxil FumarateUnited States · 200MG; 25MG BASE; 300MG · tablet · LaurusSame form
CompleraUnited States · 200MG; 25MG BASE; 300MG · tablet · Gilead Sciences INC

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Emtricitabine, Rilpivirine, Tenofovir disoproxil

EVIPLERA 200 mg/25 mg/245 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

200 mg + 27,5 mg + 300 mg comprimido recubierto con películaSpainMarketedAuthorised 25 Jan 2012

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Complera Film-coated TabletsTaiwan · 膜衣錠 · 嬌生股份有限公司

Packs

Pack	Code	Status
EVIPLERA 200 mg/25 mg/245 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos	687185

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Emtricitabine, Rilpivirine, Tenofovir disoproxil
Strength: 200 mg + 27,5 mg + 300 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 25 Jan 2012
Registration: 11737001
Marketing authorisation holder: Gilead Sciences Ireland Unlimited Company
Procedure: EU centralised
Supply: Diagnóstico Hospitalario